Does alvimopan enhance return of bowel function in laparoscopic right colectomy?

Area of Science:

• Gastroenterology
• Surgical Oncology
• Pharmacology

Background:

• Postoperative ileus (POI) is a common complication following bowel surgery.
• Alvimopan, a peripherally acting Mu-opioid receptor antagonist, has demonstrated efficacy in improving gastrointestinal (GI) recovery after open bowel resections.
• The effectiveness of Alvimopan in laparoscopic colectomies, a less invasive surgical approach, requires further investigation.

Purpose of the Study:

• To evaluate the impact of perioperative Alvimopan on preventing postoperative ileus (POI) in patients undergoing laparoscopic right colectomies.
• To assess the effect of Alvimopan on key recovery parameters, including time to first flatus, bowel movement, and tolerance of solid foods.
• To determine if Alvimopan influences the length of hospital stay (LOS) after laparoscopic right colectomy.

Main Methods:

• A prospective, nonrandomized trial comparing laparoscopic right colectomies performed with and without perioperative Alvimopan.
• Data collection included length of stay (LOS), time to first flatus, first bowel movement, tolerance of solid foods, and incidence of POI requiring nasogastric tube (NGT) insertion.
• Statistical analysis was performed using Student t tests to compare outcomes between the Alvimopan and control groups.

Main Results:

• Patients receiving Alvimopan demonstrated a statistically significant accelerated return of bowel function, including first flatus (P=0.03), tolerance of solid food (P=0.03), and first stool (P=0.04).
• There was a trend towards a shorter length of stay (LOS) in the Alvimopan group (P=0.07), although it did not reach statistical significance.
• Two patients who developed POI requiring NGT insertion were in the group that did not receive Alvimopan.

Conclusions:

• Alvimopan effectively enhances the return of gastrointestinal function following laparoscopic right colectomies.
• Perioperative Alvimopan administration shows potential in preventing postoperative ileus (POI) in this patient population.
• Further large-scale randomized prospective trials are warranted to confirm these findings and establish the definitive role of Alvimopan in laparoscopic colectomy recovery.